---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005850"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2026-07-31T12:00:57+00:00"
generated_at: "2026-07-31T12:05:13.439193+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical announces 1-for-5 reverse stock split effective July 31, 2026

## Summary
- Reverse stock split approved by board; no stockholder vote required under Nevada law.
- Effective 10:00 a.m. ET on July 31, 2026; split-adjusted trading begins August 4, 2026 under symbol AEMD.
- Pre-split shares: 3,249,569; post-split approx 649,914; authorized shares reduced from 100M to 20M.
- No fractional shares issued; rounding up to whole share; CUSIP changes to 00808Y703.
- Purpose: dilution management and continued compliance with Nasdaq minimum bid price rule.

## SEC filing metadata
- accession: 0001683168-26-005850
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2026-07-31T12:00:57+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316826005850/0001683168-26-005850-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316826005850/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005850
- JSON: https://secwatch.observer/filing/0001683168-26-005850.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005850.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.